Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 21.11.2019

Fiskars Corporation  NOTIFICATION 21.11.2019 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 21.11.2019 Date 21.11.2019Exchange transaction BuyShare class FSKRSAmount       1000Average price/share 11.7702 EUR  Highest price/share 11.8200 EUR Lowest price/share 11.7400 EUR Total price  11,770.20 EUR  The shares held by Fiskars Corporation on 21.11.2019: FSKRS 385,677  On behalf of Fiskars Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka   Mikko

OCEAN YIELD: FULLY UNDERWRITTEN PRIVATE PLACEMENT OF NEW SHARES

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Ocean Yield ASA (the “Company” or "Ocean Yield") has retained Arctic Securities AS, DNB Markets, part of DNB Bank ASA and Fearnley Securities AS as joint bookrunners (the “Joint Bookrunners”) and ING Bank N.V., SpareBank 1 Markets AS and Swedbank

ContextVision announces first digital pathology patent granted for its unique and objective data-generation method

STOCKHOLM – November 21, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, announce today that its proprietary Master Annotation method has received patent protection in the U.S. The U.S. Patent and Trademark Office (USPTO) has granted a patent to ContextVision for this invention, titled “method and system for detecting pathological anomalies in a digital pathology image and method for annotating a tissue slide”. ContextVision developed this method to automatically and more objectively outline specific structures in

Acquisition of four LR2 product tankers with long-term charter

Ocean Yield ASA ("Ocean Yield" or the "Company") is pleased to announce that the Company has agreed to acquire four modern LR2 product tankers with long-term charter to companies owned and guaranteed by Navig8 Topco Holdings Inc. (“Navig8 Group”) from a major Chinese leasing company. The net purchase price is around USD 132 million in total, or an average price of USD 33 million per vessel, depending on the closing date for each vessel, which is expected to be during the fourth quarter of 2019. The scrubber fitted vessels are built in 2018 and 2019 with about 9 year’s remaining bareboat

#19-1140 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact:Listing on +46 8 566 390 20 or at listings@ngm.se.  Nordic Growth Market NGM AB  About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Election of company employee representatives for the Board of Directors of Vestas Wind Systems A/S

The employees of Vestas Wind Systems A/S have held the ordinary election for representation in the Board of Directors according to the current Danish law on employee representation. The following members were elected for the next four years:  Name Place of employmentSussie Dvinge Agerbo (re Vestas Wind Systems A/S Plant & Hybrid Solutions-elected) ManagementAssistent   Peter Lindholst (re Vestas Wind Systems A/S Concept Development-elected) Vice President    The elected employee

Nyfosa issues senior unsecured bonds of MSEK 750

Nyfosa AB (”Nyfosa”) has successfully placed MSEK 750 senior unsecured bonds within the current framework of BNSEK 1.5 (ISIN: SE0012569655) with final maturity in May 2022. Total outstanding volume after the issue amounts to BNSEK 1.5. The previously issued bonds are listed on Nasdaq Stockholm and Nyfosa will apply for the new issued bonds to be admitted to trading on Nasdaq Stockholm as well. The bonds were issued at a price of 101.6%, which implies an interest margin of 300 basis points. The bonds have a floating interest rate of STIBOR 3M + 375 basis points. The proceeds from the

OptiGroup acquires Walki Medical Oy in Finland

VeliMark Oy, OptiGroup's Finnish company within the Facility, Safety & Foodservice business area, today announces the acquisition of Walki Medical Oy. Walki Medical is one of Finland's largest distributors of medical supplies with a turnover of EUR 14 million in 2018. The purchase price has not been disclosed. VeliMark, with a turnover of 45 million euros, is a leading supplier of cleaning and facility management supplies in Finland. Through the acquisition, the Facility, Safety & Foodservice business area will broaden its customer offering to include medical supplies to Finnish

Holdings in Company

Faron Pharmaceuticals Oy Company announcement, Turku, 21 November 2019 at 16:00 (EET)  TR-1: Standard form for notification of major holdings   NOTIFICATION OFMAJOR HOLDINGS (tobe sent to therelevantissuer and to theFCA in MicrosoftWord format ifpossible)i 1a. Identity of the Faronissuer or the Pharmaceuticalsunderlying issuer of Ltdexisting sharesto which votingrights areattachedii:1b. Please indicateif the issuer isa non-UK issuer (please

Obducat receives order from German customer at a value of 6 million SEK

OBDUCAT AB (publ) subsidiary Obducat Europe GmbH, a leading supplier of system solutions for lithography processing, has received a repeat order from an existing customer in Germany, for the supply of a MC 204 fully automated resist processing system. The order value amounts to approx.6 million SEK. The fully automated MC 204 resist processing system will be used for production purposes and it will be equipped with a function that enables inline quality control. The ordered tool is the second tool of this type that the customer orders and the purpose is to increase production capacity.

CELLINK launches new bioinks to further strengthen the company’s bioink portfolio

Today, CELLINK launches the next part of a multiphase bioink expansion. This phase includes the release of two new bioink series, the expansion of three existing bioink series, the release of a new thickener series and two products for enhanced cell analysis. With this launch, the company offers a wider range of tools for researchers around the world and further strengthens its bioink portfolio.New bioink series: Chitosan: Chitosan is an abundant biocompatible material which has been used in research related to cartilage, skin and bone tissue engineering. Previously, chitosan’s use

Repurchase of shares in Nobina

During the period 14 November  - 20 November 2019, Nobina AB (publ) (“Nobina”) repurchased a total of 154,410 Nobina shares within the framework of the repurchase programme introduced by the Board of Directors to meet the requirements arising under Nobina’s Share Saving Scheme, meaning securing the delivery of Performance Shares to the participants and securing and covering the costs for any social security contributions that may arise. The repurchase programme, which Nobina announced on 29 October 2019, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (“

Lifco issues a bond loan of SEK 1,000 million

Lifco  has issued an unsecured bond loan with a tenor of two years within its MTN program (Medium Term Notes). The bond loan amounts to SEK 1,000 million and carries a floating interest rate of three months STIBOR +0.53% annually. The bond issue generated strong investor interest and was oversubscribed. The proceeds from the bond issue will be used for refinancing of existing bank and bond loans. Lifco intends to list the new bonds on the corporate bond list of Nasdaq Stockholm. Danske Bank and SEB acted as lead banks for the issuance. Advokatfirman Vinge has

Optomed Plc applies for its shares to be listed on the official list of Nasdaq Helsinki Ltd

OPTOMED PLC          STOCK EXCHANGE RELEASE                      21 November 2019 at 3 p.m. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Optomed Plc (“Optomed” or the “Company”) has today filed a listing application with Nasdaq Helsinki Ltd (“Nasdaq Helsinki”) to list the Company’s

The CEO subscribes for issued shares for SEK 500,000

The energy storage company SaltX Technology - listed on Nasdaq First North Premier Growth Market - carries out a fully guaranteed rights issue of approximately SEK 80 million before issue costs during the period 14 - 28 November. In connection with the ongoing issue, CEO Carl-Johan Linér acquires subscription rights that entitle the holder to subscribe for 90,000 SaltX shares, which means an investment of SEK 500,000.The subscription period runs until November 28, 2019 and subscription rights are traded until November 26 at Nasdaq First North. “SaltX technology for energy storage has a

Cyxone signs a UK contract research organization for six-month toxicology studies with Rabeximod

Cyxone (publ), a Swedish biotech in autoimmune diseases, announced today that the company has signed an agreement with a UK contract research organization (CRO) to conduct the six-month toxicology studies with Rabeximod as required ahead of the Phase IIb study. Preparations for the toxicology studies began immediately with a plan of initiating the studies directly thereafter.Malin Berthold, Head of Project Management at Cyxone, comments “After thorough evaluation, we were able to decide upon this CRO as our partner of choice for these preclinical studies. The selected CRO has an excellent

Medicover adds another EUR 20 million to its outstanding Schuldschein

Medicover  AB (publ) has raised another EUR 20 million by Schuldschein. This new 10 year tranche follows the successfully executed Schuldschein transaction which Medicover closed in October, bringing the total Schuldschein transaction volume to EUR 140 million. The EUR 140 million were issued with tenors of 5, 7 and 10 years, with margins of 1.2%, 1.5% and 1.6% respectively for both fixed and floating rates. Joe Ryan, CFO commented, “Encouraged to see the investor demand, and Medicover’s flexibility to meet that demand has now enabled us to strengthen our

LFV creates smart solutions for the aviation of the future

Automation in aviation and air traffic management can contribute to improved safety, efficiency and sustainability. LFV has, jointly with Linköping University, been conducting research as part of the Automation Program since 2015. On Tuesday, their results were shown to a wider audience in Stockholm.Examples of automation in aviation include the use of artificial intelligence, AI, in air traffic management for improved safety and endurance, monitoring of movements at airports and of aircraft, risk identification in safety-critical environments and automation for training and skills

Lundbergs Interim report January - September 2019

· On September 30, 2019, net asset value after deferred tax amounted to SEK 88.0 billion (SEK 355 per share), compared with SEK 71.4 billion (SEK 288 per share) on December 31, 2018.The corresponding values on November 19, 2019 were SEK 93.7 billion (SEK 378 per share).  · Consolidated net sales amounted to SEK 16,531 m (15,420).   · Profit after financial items amounted to SEK 9,885 m. (8,822). Profit after financial items excluding unrealized changes in value amounted to SEK 6,903 m (5,486).   · Profit after taxes amounted to SEK 8,437 m (8,360) of which non-controlling

Swedish Bublar Group teams up with Amazon Game Tech for the upcoming Hello Kitty augmented reality mobile game and starts pre-registration of the game

Hello Kitty fans and gamers will, as from today, be able to pre-register for the location based mobile game “Hello Kitty AR: Kawaii World” that will go live during 2020. The famous Hello Kitty-character, founded by Japanese Sanrio, is one of the highest grossing media franchises in the world. The game, under production by the XR technology company Bublar, will use Amazon Game Tech´s backend infrastructure. We now celebrate Hello Kitty´s 45th birthday month with an announcement trailer and a landing page. Fans and players that has pre-registered will be pioneers. They will be the first

Transactions in connection with share buy-back programme 14 - 20 November 2019

On 7 November 2019, Vestas initiated a share buy-back programme, ref. Company announcement No. 17/2019 . The programme is implemented in accordance with Regulation No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour” rules). Under the programme, Vestas will buy back shares for an amount up to DKK 1,500m (approx. EUR 200m) in the period

SDLP - Seadrill Partners LLC Announces Third Quarter 2019 Results

Highlights · Operating revenue of $184.8 million · Operating income of $13.0 million · Net loss of $54.2 million · Adjusted EBITDA of $91.9 million · Cash and cash equivalents of $653.6 million · Economic utilization of 95% · Order backlog of $512 million as of November 21, 2019 · 1 cent per common unit distribution for the third quarter of 2019 Financial Results OverviewTotal operating revenues for the third quarter were $184.8 million (2Q19: $178.5 million). The increase was primarily due to a full quarter of operations for the West Aquarius and West

Peptonic closes a private placement transaction with Vidarstiftelsen

Stockholm, November 21st, 2019 - Peptonic Medical AB (‘Peptonic’ or ‘Company’) today announces that it has closed a private placement transaction with Vidarstiftelsen. The transaction comprised 11 million shares at a subscription price of SEK 2.00 per share. The subscription price was SEK 0.01 above the volume weighted average trading price of the Peptonic share for the period 13th thru 19th of November, 2019. Net proceeds of this placement are SEK 22 million.-      We are honoured and proud that Vidarstiftelsen has decided to invest in Peptonic, says Hans von Celsing, Chairman of the Board

There are no items matching the current filter
There are no more items matching the current filter
Back to top